⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) – Contact Levi & Korsinsky
accessnewswire.com
SPRY
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Filing Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Filing Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
globenewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Filing Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY